Navigation Links
Positive Phase II Study of Pacira's EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
Date:12/6/2008

Findings as reported in the poster include:

  • Statistically significant reduction in pain versus Bup/epi in patients receiving EXPAREL 450mg at the end of general anesthesia, 5.0 vs. 7.0 pain intensity (P<0.05).
  • Statistically significant reduction in pain at the time of first opioid use in both EXPAREL 300mg and 450mg patient groups versus active control, 6.4 vs. 7.8 pain intensity and 6.1 vs. 7.8 pain intensity respectively (P<0.05).
  • Pain intensity was also lower with EXPAREL than with Bup/epi during activity at all postoperative intervals evaluated.
  • EXPAREL 450mg also significantly decreased the use of opioid rescue medications throughout the entire evaluation period plus postoperative nausea and vomiting occurrence was 40% lower than in the active control group.
    • Approximately 8% of patients in the EXPAREL 450mg group avoided all opioid use versus zero percent (0%) of patients in the active control group.
  • No differences were found in the safety profile of EXPAREL compared with bupivacaine. There were no clinical signs of either cardiac or central nervous system adverse events.

The multi-center, double-blind, randomized Phase II study used a parallel-group, active-control format to evaluate the efficacy and safety of EXPAREL for prolonged postoperative analgesia. Either a single intraoperative administration of EXPAREL or active control was given via local infiltration to 103 adult patients undergoing TKA in 5 centers across the U.S. and Europe.

TKA is the leading orthopedic surgery in the U.S. with approximately 534,000 procedures performed annually according to the National Center for Health Statistics. It is expected that the number of total knee replacement procedures will increase as our population continues to age. <
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Kiadis Pharma Announces Positive Clinical Results for ATIR(TM) in Mismatched Bone Marrow Transplantations
2. Third Pivotal Phase 3 Study for NicOx Naproxcinod Shows Positive Efficacy, Safety and Blood Pressure Results
3. Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union
4. Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia
5. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
6. Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
7. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
8. VIA Pharmaceuticals Announces Positive Results of Phase 2 Studies of VIA-2291 in Patients With Serious Cardiovascular Disease
9. Poniard Pharmaceuticals Announces Final Top-Line Results from Phase 1 Trial Demonstrating Positive Bioavailability with Oral Picoplatin
10. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
11. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX), a clinical-stage drug development ... announced that J.J. Finkelstein , chief executive officer ... at two upcoming investor conferences. Mr. ... Annual Microcap Conference on Thursday May 28, 2015 in ... am EDT.  A webcast will be available at the ...
(Date:5/22/2015)... -- The Mesothelioma Victims Center is incredibly passionate about ... best possible compensation, and they are also extremely focused ... caused by exposure to asbestos or their family ... options such as a recent possible medical breakthrough. For ... anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
(Date:5/22/2015)... May 22, 2015 Research and Markets ... of the "Latest Regulations on Pharmaceutical International ... their offering. This is first time ... guidance on international multi-center clinical trials of drugs ... begun to be implemented on March 1, 2015. ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 52015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
(Date:5/26/2015)... May 26, 2015 General Networks ... MarkLogic Corporation. The alliance ensures joint customers will ... and General Networks’ expertise in building enterprise content ... MarkLogic will help customers integrate, manage and operationalize ... business processes. , “Our customers are seeking tools ...
(Date:5/26/2015)... Foot and Ankle Specialists of ... Leone (Pasadena and Baltimore Divisions) was recently presented ... Medical Association (MPMA) President from 2013 to 2015 at ... Doctorate in Podiatric Medicine from Temple University in 1999 ... in Voorhees, New Jersey. Dr. Leone is an ...
(Date:5/26/2015)... Virginia (PRWEB) May 26, 2015 U.S. ... devices in the United States are extensive and can ... consulting firm that helps medical device companies comply with ... help medical device companies navigate FDA requirements. , ... in the United States can be a lengthy process ...
(Date:5/26/2015)... GA (PRWEB) May 26, 2015 The ... Associates are at it again, helping local rescue pets ... 2015. Local dentists, Kirk Kimmerling DDS, Suzanna Aguilera ... veterinarian, Julian Peckich DVM donating 100% of proceeds from ... to fill the parking lot to help save unwanted, ...
(Date:5/25/2015)... TX (PRWEB) May 26, 2015 ... 2015” provides comprehensive information on the therapeutic development ... by identifying new targets and MOAs to produce ... 2015 pipeline review of Liver Failure with 22 ... 65 pages is available at http://www.rnrmarketresearch.com/liver-failure-pipeline-review-h1-2015-market-report.html ...
Breaking Medicine News(10 mins):Health News:General Networks Corporation Announces Alliance with MarkLogic 2Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives MPMA Service Award 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 2Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 3Health News:FDA Medical Device Regulations: Top 10 Tips for Marketing a Device in the USA 4Health News:"Rescue Animal Cookout" Announced at Verde Pointe Professional Park on June 25, 2015 2Health News:Liver Failure Pipeline Assessment and Key Players Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Liver Failure Pipeline Assessment and Key Players Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Liver Failure Pipeline Assessment and Key Players Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4
... researcher says he completed the task for $50,000 , ... he was able to sequence his entire genome for less ... "This is the first demonstration that you don,t need a ... professor of engineering at Stanford University, said in a news ...
... lead to protein deficiency , , TUESDAY, Aug. 11 ... muscular dystrophy has been identified by Japanese researchers. , ... with muscular dystrophy and degeneration of their fat tissue, ... but they did not have mutations in the caveolin-3 ...
... ... and medical equipment will now be widely available to healthcare professionals online via Target.com. ... faces during doctors, visits so they will be more relaxed and cooperative, improving productivity ... ...
... , KENILWORTH, N.J., Aug. 11 Schering-Plough Corporation (NYSE: ... antihistamine eye drop strong enough to control itchy eyes all day or ... sold, CLARITIN Eye works in minutes to relieve the itch of allergy ... , To view the Multimedia News Release, go to: ...
... Conn., Aug. 11 VION PHARMACEUTICALS, INC. (OTC ... periods ending June 30, 2009. , , For the ... million, or $0.83 per share compared with a net loss of $7.9 ... common shares outstanding for the three months ended June 30, 2009 and ...
... , , , , ... Fort Worth personal injury attorney John David Hart has filed ... Puerto Rico, Inc., Medtronic USA, Inc. and Medtronic Puerto Rico Operations ... risk of lead fractures which could result in serious injury or ...
Cached Medicine News:Health News:Genome Sequencing Gets More Affordable 2Health News:PediaPals to Market Pediatric Exam Tables and Medical Equipment on Target.com 2Health News:PediaPals to Market Pediatric Exam Tables and Medical Equipment on Target.com 3Health News:Photos: New CLARITIN(R) Eye Relieves Itchy Eyes For Up To 12 Hours 2Health News:Photos: New CLARITIN(R) Eye Relieves Itchy Eyes For Up To 12 Hours 3Health News:Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results 2Health News:Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results 3Health News:Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results 4Health News:Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results 5Health News:Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results 6Health News:Texas Law Firm Files Multiple Suits Against Medtronic as Deadline Approaches 2
View Mex-2 is designed for out-patient surgery, hospital rounds and house calls....
Fiberoptic lightweight coaxial rotary headlight with variable spot....
It is a magnifying headlight perfect for all applications and procedures where clear magnification and a natural white light increase accuracy and productivity....
... It is powerful, ... very comfortable, soft, durable ... cushion pad, covered by ... wrap. Flexible headband easily ...
Medicine Products: